Lenti-human-UBDUB-gRNA-puromycin-IRES-CFP Citations (2)
Originally described in: Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens.Wright S, Hu J, Wang H, Hyle J, Zhang Y, Du G, Konopleva MY, Kornblau SM, Djekidel MN, Rosikiewicz W, Xu B, Lu R, Yang JJ, Li C Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2220134120. doi: 10.1073/pnas.2220134120. Epub 2023 Apr 10. PubMed Journal
Articles Citing Lenti-human-UBDUB-gRNA-puromycin-IRES-CFP
| Articles |
|---|
Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens.
Wright S, Hu J, Wang H, Hyle J, Zhang Y, Du G, Konopleva MY, Kornblau SM, Djekidel MN, Rosikiewicz W, Xu B, Lu R, Yang JJ, Li C.
Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2220134120. doi: 10.1073/pnas.2220134120. Epub 2023 Apr 10.
PubMed
Associated Plasmids |
| ASB6 as an Independent Prognostic Biomarker for Colorectal Cancer Progression Involves Lymphatic Invasion and Immune Infiltration. Hu Q, Chen Y, Zhou Q, Deng S, Mu B, Tang J. J Cancer. 2024 Mar 17;15(9):2712-2730. doi: 10.7150/jca.93066. eCollection 2024. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.